{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:22:31Z","timestamp":1759602151527},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.bcp.2003.10.027","type":"journal-article","created":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T16:48:52Z","timestamp":1072111732000},"page":"1057-1064","source":"Crossref","is-referenced-by-count":16,"title":["Tamoxifen cytotoxicity in hepatoblastoma cells stably transfected with human CYP3A4"],"prefix":"10.1016","volume":"67","author":[{"given":"Adam","family":"Holownia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J","family":"Braszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2003.10.027_BIB1","first-page":"151","article-title":"Basic guide to the mechanisms of antiestrogen action","volume":"50","author":"MacGregor","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2003.10.027_BIB2","first-page":"S1","article-title":"Review of the toxicology of tamoxifen","volume":"24","author":"Wogan","year":"1997","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s002040100244","article-title":"Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat","volume":"75","author":"Carthew","year":"2001","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-2952(96)00650-8","article-title":"Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes","volume":"53","author":"Crewe","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/carcin\/17.6.1357","article-title":"The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme\u2013substrate interactions: potential importance to its proposed anti-carcinogenic\/carcinogenic actions","volume":"17","author":"Wiseman","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2003.10.027_BIB6","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/jnci\/94.21.1635","article-title":"Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy","volume":"94","author":"Nowell","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcp.2003.10.027_BIB7","first-page":"609","article-title":"Sulfotransferase 1A2\u22172 is a risk factor for early-onset breast cancer","volume":"10","author":"Hou","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2003.10.027_BIB8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0006-2952(02)00994-2","article-title":"Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases","volume":"63","author":"Nishiyama","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB9","first-page":"932","article-title":"Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4","volume":"24","author":"Feierman","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.10.027_BIB10","unstructured":"Morasca L, Erba E. Animal cell culture, a practical approach. Oxford, UK: IRL Press; 1986."},{"key":"10.1016\/j.bcp.2003.10.027_BIB11","first-page":"119","article-title":"Measurement of cellular activity with the MTT test. Optimization of the method","volume":"37","author":"Bank","year":"1991","journal-title":"Allergy Immunol. Leipz."},{"key":"10.1016\/j.bcp.2003.10.027_BIB12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q","article-title":"Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V\/propidium iodide assay","volume":"44","author":"Lecoeur","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.bcp.2003.10.027_BIB13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-679X(01)64014-7","article-title":"Monitoring of cellular resistance to cancer chemotherapy: drug retention and efflux","volume":"64","author":"Krishan","year":"2001","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/carcin\/22.6.839","article-title":"Understanding the genotoxicity of tamoxifen?","volume":"22","author":"Phillips","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2003.10.027_BIB15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s002040100244","article-title":"Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat","volume":"75","author":"Carthew","year":"2001","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB16","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/0006-2952(94)90319-0","article-title":"Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes","volume":"47","author":"Berthou","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB17","first-page":"681","article-title":"Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins","volume":"27","author":"Dehal","year":"1999","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.10.027_BIB18","first-page":"645","article-title":"Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation","volume":"21","author":"Mani","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.10.027_BIB19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-2952(96)00650-8","article-title":"Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes","volume":"53","author":"Crewe","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/carcin\/20.1.153","article-title":"Alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro","volume":"20","author":"Boocock","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2003.10.027_BIB21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/carcin\/21.10.1851","article-title":"Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts","volume":"21","author":"Boocock","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2003.10.027_BIB22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3109\/00498259509061915","article-title":"Drug toxicity mechanisms in human hepatoma HepG2 cells: cyclosporin A and tamoxifen","volume":"25","author":"Duthie","year":"1995","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2003.10.027_BIB23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3835(99)00284-0","article-title":"Involvement of Ca2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells","volume":"147","author":"Kim","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2003.10.027_BIB24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0026-0495(98)90078-6","article-title":"Effect of tamoxifen on cholesterol synthesis in HepG2 cells and cultured rat hepatocytes","volume":"47","author":"Holleran","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2003.10.027_BIB25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endo-120-1-133","article-title":"Effect of mestranol on cell proliferation and angiotensinogen production in HepG2 cells: relation with the cell cycle and action of tamoxifen","volume":"120","author":"Coezy","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2003.10.027_BIB26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-2952(94)90099-X","article-title":"Antiestrogens and steroid hormones: substrates of the human p-glycoprotein","volume":"48","author":"Rao","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB27","first-page":"6859","article-title":"Phenol sulfotransferases: hormonal regulation polymorphism and age of onset of breast cancer","volume":"60","author":"Seth","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2003.10.027_BIB28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0027-5107(01)00207-X","article-title":"Human cytosolic sulphotransferases: genetics characteristics toxicological aspects","volume":"482","author":"Glatt","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bcp.2003.10.027_BIB29","first-page":"2887","article-title":"Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction","volume":"60","author":"Davis","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2003.10.027_BIB30","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0006-2952(02)00994-2","article-title":"Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases","volume":"63","author":"Nishiyama","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2003.10.027_BIB31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/carcin\/23.3.491","article-title":"Change in the gene expression of hepatic tamoxifen-metabolizing enzymes during the process of tamoxifen-induced hepatocarcinogenesis in female rats","volume":"23","author":"Kasahara","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2003.10.027_BIB32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/carcin\/22.8.1307","article-title":"DNA adduct formation and mutant induction in Sprague\u2013Dawley rats treated with tamoxifen and its derivatives","volume":"22","author":"da Costa","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2003.10.027_BIB33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-2797(97)00133-6","article-title":"Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems","volume":"109","author":"Glatt","year":"1998","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2003.10.027_BIB34","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/carcin\/23.11.1947","article-title":"The mutational signature of alpha-hydroxytamoxifen at Hprt locus in Chinese hamster cells","volume":"23","author":"Yadollahi-Farsani","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2003.10.027_BIB35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/carcin\/22.4.553","article-title":"Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar\/Han rats","volume":"22","author":"White","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2003.10.027_BIB36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1053\/jhep.2002.36824","article-title":"Asian-Pacific Hepatocellular Carcinoma Trials Group. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: a multicenter randomized controlled trial","volume":"36","author":"Chow","year":"2002","journal-title":"Hepatology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295203008682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295203008682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T08:15:55Z","timestamp":1549613755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295203008682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0006295203008682"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2003.10.027","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}